Human
APIs
We contribute to improving healthcare by providing high-quality APIs
In the Human API division of Suanfarma, we have a dedicated commercial team that provides an attractive and tailored portfolio for each customer, supported by our Quality and Regulatory Affairs departments.
With over 400 molecules for human pharmacological use, we comprehensively address different illnesses and therapeutic areas of interest to the pharmaceutical industry. Our range includes antibiotics, antivirals, antifungals, respiratory, oncological, cardiovascular products, and more.
Our success is grounded in the continuous search for new development proposals and alternative sources for all pharmacological groups. This commitment positions us at the forefront of innovation, guided by robust metrics and in-depth market studies, ensuring we meet the evolving needs of our customers.
We ensure compliance with Good Manufacturing Practices and closely monitor current legislation regarding proper distribution standards, guidelines, and international regulations applicable to the pharmaceutical industry. Furthermore, we possess all necessary marketing authorizations for our raw materials across global markets.
Proprietary APIs
THERAPEUTIC INDICATION | API | CEP/DMF | STATUS |
---|---|---|---|
ANTIBIOTIC | LYMECYCLINE | CEP | COMMERCIAL |
MINOCYCLINE HYDROCHLORIDE | CEP, DMF | COMMERCIAL | |
MUPIROCIN | UNDER DEVELOPMENT | ||
OXYTETRACYCLINE CALCIUM | DMF | COMMERCIAL | |
OXYTETRACYCLINE DIHYDRATE | COMMERCIAL | ||
TETRACYCLINE HYDROCHLORIDE | CEP, DMF | COMMERCIAL | |
ANTIDIABETIC | CANAGLIFLOZIN HEMIHYDRATE | UNDER DEVELOPMENT | |
EMPAGLIFLOZIN | UNDER DEVELOPMENT | ||
ANTINEOPLASTIC AGENT | RIBOCICLIB SUCCINATE | UNDER DEVELOPMENT | |
OVULATION STIMULANT | CLOMIFENE CITRATE | CEP | COMMERCIAL |
Strategic APIs
CHLORHEXIDINE BASE
DEXTROMETHORPHAN
ENOXAPARIN
FAMOTIDINE
PREGABALIN
RIVAROXABAN
THYROID POWDER
TRIMEBUTINE MALEATE
Strategic APIs
THERAPEUTIC INDICATION | API | CEP/DMF | STATUS |
---|---|---|---|
AGENT FOR DERMATITIS | CRISABOROLE | UNDER DEVELOPMENT | |
ANTIBIOTIC | AZITHROMYCIN | CEP, DMF | COMMERCIAL |
CIPROFLOXACIN | CEP, DMF | COMMERCIAL | |
CLARITHROMYCIN | CEP, DMF | COMMERCIAL | |
DOXYCYCLINE HYCLATE | COMMERCIAL | ||
MOXIFLOXACIN HYDROCHLORIDE | COMMERCIAL | ||
ROXITHROMYCIN | CEP, DMF | COMMERCIAL | |
ANTI-DEMENTIA | GALANTAMINE HYDROBROMIDE | CEP, DMF | COMMERCIAL |
ANTIDEPRESSANT | AGOMELATINE | COMMERCIAL | |
CITALOPRAM | CEP, DMF | COMMERCIAL | |
FLUVOXAMINE MALEATE | COMMERCIAL | ||
ANTIDIABETIC | SITAGLIPTIN PHOSPHATE MONOHYDRATE | DMF | COMMERCIAL |
ANTIEMETIC | APREPITANT | CEP, DMF | COMMERCIAL |
ANTIEPILEPTIC | CARBAMAZEPINE | CEP, DMF | COMMERCIAL |
ESLICARBAZEPINE ACETATE | CEP, DMF | COMMERCIAL | |
LAMOTRIGINE | CEP, DMF | COMMERCIAL | |
OXCARBAZEPINE | CEP, DMF | COMMERCIAL | |
ANTINEOPLASTIC AGENT | ANASTROZOLE | CEP | COMMERCIAL |
CABOZANTINIB | UNDER DEVELOPMENT | ||
PACRITINIB CITRATE | UNDER DEVELOPMENT | ||
PONATINIB | UNDER DEVELOPMENT | ||
SELUMETINIB | UNDER DEVELOPMENT | ||
TRAMETINIB | UNDER DEVELOPMENT | ||
ANTI-PARATHYROID AGENT | CINACALCET | COMMERCIAL | |
ANTIPSYCHOTICS | ARIPIPRAZOLE | CEP, DMF | COMMERCIAL |
CARIPRAZINE HYDROCHLORIDE | COMMERCIAL | ||
OLANZAPINE | CEP, DMF | COMMERCIAL | |
QUETIAPINE FUMARATE | CEP, DMF | COMMERCIAL | |
RISPERIDONE | CEP, DMF | COMMERCIAL | |
ANTITHROMBOTIC AGENT | RIVAROXABAN | DMF | COMMERCIAL |
BETA BLOCKING AGENT | BISOPROLOL FUMARATE | CEP | COMMERCIAL |
ERECTILE DYSFUNCTION | TADALAFIL | CEP, DMF | COMMERCIAL |
HORMONE ANTAGONIST | RELUGOLIX | UNDER DEVELOPMENT | |
INMUNOSUPPRESSANT | PIRFENIDONE | CEP, DMF | COMMERCIAL |
NERVOUS SYSTEM | PATISIRAN | UNDER DEVELOPMENT | |
OPIOID | TRAMADOL HYDROCHLORIDE | CEP, DMF | COMMERCIAL |
PSYCHOLEPTIC | SUVOREXANT | UNDER DEVELOPMENT | |
RESPIRATORY SYSTEM | ELEXACAFTOR | UNDER DEVELOPMENT | |
URINARY FREQUENCY AND INCONTINENCE | MIRABEGRON | COMMERCIAL | |
SOLIFENACIN SUCCINATE | CEP, DMF | COMMERCIAL |
Top distribution APIs
ALPHA LIPOIC ACID
ALPHA LIPOIC ACID COATED
BEMPEDOIC ACID
BOSENTAN
CHLORTHALIDONE
CITALOPRAM
COLISTIMETHATE SODIUM
ESCITALOPRAM
ESOMEPRAZOLE
FEXOFENADINE
FLUCONAZOLE
GABAPENTIN
HEPARIN SODIUM CRUDE
IMATINIB MESYLATE
LAMOTRIGINE
LINAGLIPTIN
MEMANTINE
OMEPRAZOLE
PANTOPRAZOLE
PIDOTIMOD
QUETIAPINE FUMARATE
TEMOZOLAMIDE
TRAMADOL
URSODEOXYCHOLIC ACID
Research and development
API | USE |
---|---|
EMPAGLIFLOZIN | Antidiabetic |
IBRUTINIB | Oncology |
IMLIFIDASE | Avoid rejection in kidney transplantation |
LEMBOREXANT | Psycholeptics |
LUMATEPERONE | Antipsychotic |
PALBOCICLIB | Oncology |
SAFINAMIDE | Parkinson |
TIVOZANIB | Oncology |
VIBEGRON | Urinary Antiespasmodics |
VOCLOSPORIN | Lupus Nephritis |
Items covered by valid patents are not offered or supplied for commercial use. Products under patent are available for R&D use only
experience
supports us
APIs
Other products developed and manufactured under exclusive character
Contact us and we will provide you with details of our extensive product portfolio.
If you do not find the product you are looking for or are interested in developing a new one, please contact us.
APIs
experience
supports us
Other products developed and manufactured under exclusivity
If you cannot find the product you are looking for or are
interested in developing a new one, please contact us.